3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Agnosia
2
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Lymphoma
1
Kidney Neoplasms
1
Ileus
1
Head and Neck Neoplasms
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Curative Breast Cancer Surgery
1
Constipation
1
Colonic Neoplasms
1
Chronic Pain
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Female
1
Acute Pain
1
Interventions
Morphine
6
Surveys and Questionnaires
5
Ketamine
4
Sodium Chloride
3
Saline Solution
3
Lidocaine
3
Educational Status
3
Dexmedetomidine
3
Cognitive Behavioral Therapy
3
Anesthetics, Local
3
Pregabalin
2
Mindfulness-Based Stress Reduction
2
Hypnosis
2
Fentanyl
2
Bupivacaine
2
Botulinum Toxins, Type A
2
Acetaminophen
2
ziconotide
1
tianeptine
1
siltuximab
1
onabotulinum toxin A
1
erenumab
1
Yoga
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Tramadol
1
Therapeutics
1
Telemedicine
1
Tea
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Chronic Pain
×
Ketorolac Tromethamine
×
Clear all
NCT01789216
2021-02-03
PAIN
Major Extremity Trauma Research Consortium
Phase 3
Completed
450 enrolled